DI BELLA METHOD > DOCUMENTATION INDEX > MDB - Documents

 
 
MDB - Documents
 
 
Somatostatin analog RC-160 inhibits the growth of human osteosarcomas in nude mice. (30/05/2003)
Detail
Somatostatin analog SMS 201995 inhibits proliferation in human leukemia T-cell line: relevance of the adenylyl cyclase stimulation. (30/05/2003)
Detail
Chronic subcutaneous octreotide decreases gastrointestinal blood loss in blue rubber-bleb nevus syndrome. (30/05/2003)
Detail
Octreotide for cancer of the liver and biliary tree. (30/05/2003)
Detail
Octreotide combined with goserelin in the therapy of advanced pancreatic cancer--results of a pilot study and review of the literature. (30/05/2003)
Detail
Octreotide improves biochemical, radiologic, and symptomatic indices of gastroenteropancreatic neoplasia in patients with multiple endocrine neoplasia type 1 (MEN-1). Implications for an integrated model of MEN-1 tumorigenesis. (30/05/2003)
Detail
Octreotide in the treatment of advanced pancreatic tumor. Preliminary study] (30/05/2003)
Detail
Octreotide in the treatment of severe chemotherapy-induced diarrhea. (30/05/2003)
Detail
The somatostatin analogue octreotide inhibits neuroblastoma growth in vivo. (30/05/2003)
Detail
The use of Sandostatin in the combined treatment of surgical diseases of the pancreas] (30/05/2003)
Detail
TSH-secreting pituitary macroadenoma: rapid tumor shrinkage and recovery from hyperthyroidism with octreotide. (30/05/2003)
Detail
No loss of sst receptors gene expression in advanced stages of colorectal cancer (30/05/2003)
Detail
Lack of evidence for cross-competition between vasoactive intestinal peptide and somatostatin at their respective receptors. (30/05/2003)
Detail
Mechanisms of antineoplastic action of somatostatin analogs. (30/05/2003)
Detail
Antineoplastic mechanism of Octreotide action in human hepatoma. (30/05/2003)
Detail
 
 
 
Scorri con le frecce per visualizzare le pagine della ricerca 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 |
 
 

Stampa